ACCEPTED MANUSCRIPT (published today Oct 20, 2020)
Post# of 148166
(Total Views: 536)
Posted On: 10/20/2020 2:43:22 PM
ACCEPTED MANUSCRIPT (published today Oct 20, 2020)
Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab
Bryant Yang, M.D, Jennifer A Fulcher, M.D, Jenny Ahn, R.N, Marlene Berro, M.S, David Goodman-Meza, M.D, Kush Dhody, M.B.B.S, Jonah B Sacha, Ph.D, Arash Naeim, M.D, Otto O Yang, M.D
Clinical Infectious Diseases, ciaa1583, https://doi.org/10.1093/cid/ciaa1583
Published: 20 October 2020 Article history
https://academic.oup.com/cid/advance-article/...83/5932277
Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab
Bryant Yang, M.D, Jennifer A Fulcher, M.D, Jenny Ahn, R.N, Marlene Berro, M.S, David Goodman-Meza, M.D, Kush Dhody, M.B.B.S, Jonah B Sacha, Ph.D, Arash Naeim, M.D, Otto O Yang, M.D
Clinical Infectious Diseases, ciaa1583, https://doi.org/10.1093/cid/ciaa1583
Published: 20 October 2020 Article history
https://academic.oup.com/cid/advance-article/...83/5932277
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼